6052 | BioNTech phase 2 (Walsh), 2020 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
6560 | Chodcik, 2021 | 1 | 13 | 3 | | not a RCT | high risk of bias |
6650 | Dagan, 2021 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
6663 | SIREN (HW england), 2021 | 1 | 10 | 3 | | not a RCT | high risk of bias |
6664 | Scotland cohort, 0 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
6668 | Amit, 2021 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
6757 | Levine-Tiefenbrun, 2021 | 0 | 0 | 0 | selection pending |
6766 | Pfizer 16-25 years phase 3, 0 | 2 | 1 | 0 | excluded | | risk of bias not avaialble |
6792 | Weekes, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
6944 | Yanay, 2021 | 1 | 32 | 0 | | not a RCT | risk of bias not avaialble |
6949 | Pawlowski, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
6953 | Goldberg, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
6961 | Zadok, 2021 | 1 | 32 | 0 | | not a RCT | risk of bias not avaialble |
6965 | Bernal (PHE, 19th February 2021), 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
6989 | Palich, 2021 | 1 | 32 | 0 | | not a RCT | risk of bias not avaialble |
6999 | Rozen-Zvi, 2021 | 1 | 32 | 0 | | not a RCT | risk of bias not avaialble |
7002 | Haas, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
7003 | Abu-Raddad, 2021 | 1 | 20 | 0 | | not a RCT | risk of bias not avaialble |
7005 | Tang, 2021 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
7006 | Angel, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
7957 | Haas, 2021 | 1 | 0 | 0 | | | risk of bias not avaialble |
8270 | Heymann, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
8271 | Bjork, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
8273 | Goshen-Lago, 2021 | 0 | 0 | 0 | selection pending |
8338 | Wan, 2021 | 1 | 20 | 4 | | not a RCT | high risk of bias |
8346 | Walter E.B. (Children <12 Years of Age), 2021 | 1 | 1 | 0 | | | risk of bias not avaialble |
8351 | Tenforde, 2021 | 1 | 20 | 3 | | not a RCT | high risk of bias |
8352 | Nanduri, 2021 | 1 | 13 | 3 | | not a RCT | high risk of bias |
8506 | Barda, 2021 | 1 | 13 | 4 | | not a RCT | high risk of bias |
8507 | Klein, 2021 | 1 | 13 | 4 | | not a RCT | high risk of bias |
8517 | EPI-PHARE, 2021 | 1 | 13 | 4 | | not a RCT | high risk of bias |
9172 | South Africa (Discovery Health, Collie), 2021 | 1 | 20 | 0 | | not a RCT | risk of bias not avaialble |
9203 | England (Andrews), 2021 | 1 | 20 | 0 | | not a RCT | risk of bias not avaialble |
9216 | Sultan, 2022 | 0 | 12 | 0 | selection pending |
9217 | June, 2021 | 1 | 12 | 0 | | not a RCT | risk of bias not avaialble |
9218 | Coggiola, 2021 | 0 | 99 | 0 | selection pending |
9230 | Burns, 2022 | 2 | 0 | 0 | excluded | | risk of bias not avaialble |
9244 | Richardson, 2022 | 0 | 0 | 0 | selection pending |
9248 | Watanabe, 2021 | 0 | 0 | 0 | selection pending |
9261 | xie, 2021 | 0 | 0 | 0 | selection pending |
9272 | Lustig, 2021 | 0 | 0 | 0 | selection pending |
9316 | Shibli, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
9323 | Nguyen, 2022 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
9346 | Simpson (Comirnaty), 2021 | 0 | 12 | 0 | selection pending |
9359 | Husby (pfizer), 2021 | 1 | 12 | 0 | | not a RCT | risk of bias not avaialble |
9370 | Kanokudom, 2022 | 0 | 0 | 0 | selection pending |
9381 | Edward (pfizer), 2021 | 1 | 13 | 4 | | not a RCT | high risk of bias |
9382 | Burn (Pfizer), 2021 | 1 | 13 | 4 | | not a RCT | high risk of bias |
9415 | Patalon, 2022 | 1 | 20 | 0 | | not a RCT | risk of bias not avaialble |
9445 | Kawasuji, 2022 | 2 | 0 | 0 | excluded | | risk of bias not avaialble |
9466 | Falsey, 0 | 2 | 0 | 0 | excluded | | risk of bias not avaialble |
9485 | Molteni, 2022 | 2 | 0 | 0 | excluded | | risk of bias not avaialble |
9487 | Shemer, 2021 | 1 | 11 | 0 | | not a RCT | risk of bias not avaialble |
9492 | Patone, 2021 | 1 | 12 | 0 | | not a RCT | risk of bias not avaialble |
9585 | Shasha, 2021 | 1 | 12 | 0 | | not a RCT | risk of bias not avaialble |
9591 | Veneti, 2022 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
9592 | Tartof, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
9592 | Tartof, 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
9593 | Lutrick (PROTECT study), 2021 | 1 | 10 | 0 | | not a RCT | risk of bias not avaialble |
9603 | Price, 2022 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
9604 | Glatman-Freedman A, 2021 | 1 | 12 | 0 | | not a RCT | risk of bias not avaialble |
9605 | Olson (July to October), 2022 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
9608 | Olson (June to September), 2021 | 1 | 13 | 0 | | not a RCT | risk of bias not avaialble |
9609 | Reis, 2021 | 1 | 12 | 0 | | not a RCT | risk of bias not avaialble |
9612 | Klein ( VISION network), 2022 | 1 | 12 | 0 | | not a RCT | risk of bias not avaialble |